Caris Life Sciences, Inc. Common Stock (CAI) — Capital Reinvestment Ratio
Caris Life Sciences, Inc. Common Stock (CAI) has a Capital Reinvestment Ratio of 0.31x as of March 2026, meaning it reinvests 0% of its operating cash flow ($32.88 Million) in capital expenditures ($10.34 Million). See CAI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Caris Life Sciences, Inc. Common Stock Capital Reinvestment Ratio (2005–2025)
This chart tracks Caris Life Sciences, Inc. Common Stock's Capital Reinvestment Ratio across 16 annual periods.
Annual Capital Reinvestment Ratio for Caris Life Sciences, Inc. Common Stock (2005–2025)
Year-by-year Capital Reinvestment Ratio for Caris Life Sciences, Inc. Common Stock from 2005 to 2025. For live market cap and broader valuation context, see CAI stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $83.16 Million | $16.26 Million | ▼ -75.3% |
| 2020 | 0.79x | $277.02 Million | $219.45 Million | ▼ -37.0% |
| 2019 | 1.26x | $254.00 Million | $319.14 Million | ▼ -72.2% |
| 2018 | 4.52x | $179.77 Million | $812.84 Million | ▲ +39.7% |
| 2017 | 3.24x | $155.19 Million | $502.18 Million | ▲ +66.5% |
| 2016 | 1.94x | $129.26 Million | $251.25 Million | ▼ -26.4% |
| 2015 | 2.64x | $147.37 Million | $389.41 Million | ▲ +20.1% |
| 2014 | 2.20x | $139.69 Million | $307.31 Million | ▼ -12.5% |
| 2013 | 2.51x | $124.19 Million | $312.20 Million | ▼ -48.8% |
| 2012 | 4.91x | $106.83 Million | $524.60 Million | ▼ -28.0% |
| 2011 | 6.82x | $72.11 Million | $491.93 Million | ▲ +39.9% |
| 2010 | 4.88x | $42.42 Million | $206.83 Million | ▲ +378.9% |
| 2009 | 1.02x | $30.80 Million | $31.35 Million | ▼ -86.3% |
| 2008 | 7.45x | $27.44 Million | $204.30 Million | ▲ +36.0% |
| 2006 | 5.47x | $8.38 Million | $45.85 Million | ▲ +45910.8% |
| 2005 | 0.01x | $29.41 Million | $350.00K | — |